FindTrial
Sign In

To find the role of streptokinase in the management of loculated empyema and loculated parapneumonic effusion at tertiary centre.

Role of streptokinase in the management of loculated empyema and loculated parapneumonic effusion at tertiary centre.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027834
Enrollment
48
Registered
2020-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J90- Pleural effusion, not elsewhere classified

Interventions

Intervention1: Intercostal drainage along with Streptokinase: 300000 unit diluted in 100 ml NS will be installed through intercostal drainage tube, 8 hourly for 3 days. Intercostal drainage will be cl

Sponsors

School of Medical Sciences Research and Sharda Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the patients, those will be diagnosed as loculated empyema and loculated parapneumonic effusion, willing to participate in this study having no exclusion criteria will be enrolled in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with duration of illness for more than 3 months. 2. Patients with previous history of pulmonary tuberculosis. 3. Patients with history of CAD and streptokinase infusion. 4. Patients not willing to participate in our study

Design outcomes

Primary

MeasureTime frame
Plain computed tomographyTimepoint: On 7th day of intercostal drainage insertion—

Secondary

MeasureTime frame
SpirometryTimepoint: On 15th day of ICD insertion for improvement in forced vital capacity.—

Countries

India

Contacts

Public ContactMukesh Kumar

School of Medical Sciences & Research and Sharda Hospital

dr.deva29@gmail.com8979970674

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026